Elite Health Systems Inc.
Datakwaliteit: 100%
EHSI
OTC
Services
Health Services
€ 1,26
€ 0,00
(0,00%)
Marktkapitalisatie: 27,64 M
Prijs
€ 1,26
Marktkapitalisatie
27,64 M
Dagbereik
€ 1,26 — € 1,26
52-Weeksbereik
€ 0,69 — € 1,50
Volume
1.340
Openen € 1,26
50D / 200D Gem.
€ 1,29
2,63% below
50D / 200D Gem.
€ 1,31
3,85% below
Quick Summary
Belangrijkste Punten
Negative free cash flow of -1,98 M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-69,19%
Onder sectorgemiddelde (-15,74%)
ROIC-45,13%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio15,83
Interest CoverageN/A
Waardering
PE (TTM)
-9,07
Onder sectorgemiddelde (-1,17)
P/B Ratio5,51
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Services sector mediaan (502 peers)
Sectorvergelijking
vs Services sector mediaan (502 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -9,1 | -1,2 |
| P/B | 5,5 | 1,4 |
| ROE % | -69,2 | -15,7 |
| Net Margin % | — | -18,3 |
| Rev Growth 5Y % | — | 4,2 |
| D/E | — | 0,4 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -3,05 M |
| ROE | -69,19% | ROA | -65,56% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -1,98 M |
| ROIC | -45,13% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 15,83 |
| Interest Coverage | N/A | Asset Turnover | 0,00 |
| Working Capital | 4,00 M | Tangible Book Value | 5,02 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -9,07 | Forward P/E | N/A |
| P/B Ratio | 5,51 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -7,14% | ||
| Market Cap | 27,64 M | Enterprise Value | 23,67 M |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | 0,00 |
| FCF / Share | -0,09 | OCF / Share | -0,09 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 64,82% |
| SBC-Adj. FCF | -2,48 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 1,06 M | 3,17 M |
| Net Income | -2,06 M | -816.000,0 | -1,34 M | -627.000,0 | 533.000,0 |
| EPS (Diluted) | — | -0,17 | -0,17 | -0,08 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -1,79 M | -765.000,0 | -1,39 M | -89.000,0 | 1,62 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | 1,79 M | 765.000,0 | 1,39 M | 1,06 M | 1,20 M |
| D&A | — | — | — | — | — |
| Interest Expense | — | 2.000,0 | 0,0 | 3.000,0 | 25.000,0 |
| Income Tax | -163.000,0 | 0,0 | 39.000,0 | 120.000,0 | 323.000,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 4,32 M | 1,32 M | 1,75 M | 3,69 M | 4,17 M |
| Total Liabilities | 143.000,0 | 676.000,0 | 291.000,0 | 361.000,0 | 487.000,0 |
| Shareholders' Equity | 4,18 M | 645.000,0 | 1,24 M | 2,83 M | 3,69 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 4,03 M | 466.000,0 | 1,54 M | 2,18 M | 2,03 M |
| Current Assets | 4,25 M | 527.000,0 | 1,56 M | 2,24 M | 3,01 M |
| Current Liabilities | 94.000,0 | 607.000,0 | 280.000,0 | 327.000,0 | 410.000,0 |
{"event":"ticker_viewed","properties":{"ticker":"EHSI","listing_kind":"stock","pathname":"/stocks/ehsi","exchange":"OTC","country":"US"}}